Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
-
Surg Obes Relat Dis · May 2009
Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass.
Previous outcome research in bariatric surgery has been unable to document quantitative changes in co-morbidities associated with obesity owing to a lack of a standardized instrument to grade the severity. We report a detailed description of the early resolution of the metabolic syndrome using our novel scheme for assessing co-morbidities. This study was performed at a tertiary care university hospital. ⋯ We have demonstrated a new and novel approach to categorize and more accurately define the magnitude of improvement in co-morbidities after laparoscopic Roux-en-Y gastric bypass. This improvement preceded the weight loss effects on the metabolic syndrome.
-
Surg Obes Relat Dis · May 2009
Predictors for health-related quality of life in patients accepted for bariatric surgery.
The relationship among musculoskeletal pain, depression, and health-related quality of life in patients with severe obesity who are accepted for bariatric surgery should be explored further. ⋯ The results of this study have shown that musculoskeletal pain was strongly associated with lower scores on the PCS and MCS, and depression was strongly associated with a lower score on the MCS.
-
Surg Obes Relat Dis · May 2009
Practice GuidelineAmerican Society for Metabolic and Bariatric Surgery Position Statement on emerging endosurgical interventions for treatment of obesity.
The following position statement is issued by the American Society for Metabolic and Bariatric Surgery in response to numerous inquiries made to the Society by patients, physicians, society members, hospitals, health insurance payors, the media, and others regarding emerging endosurgical interventions for treatment of obesity. In this statement, the ASMBS establishes its position on the appropriate steps to be taken before acceptance of new technologies for the treatment of obesity that are based on current knowledge, careful consideration of experts, and published peer-reviewed scientific evidence available at this time. ⋯ The statement is not intended as, and should not be construed as, stating or establishing a local, regional, or national standard of care. The statement will be revised in the future as additional evidence becomes available.